NANOMEDICINES FOR TARGETED CANCER TREATMENT
Arrogene’s team of scientists has developed a family of related bio-polymer based nano agents that are capable of crossing the blood-brain-barrier. Polyolefin™ is a new drug delivery system can both identify cancer cell types through “virtual biopsies,” as well as target the molecular backbone of cancer.
Polycefin™ has been shown to be a highly effective targeted delivery platform for diagnostic imaging of tumors and other conditions through Magnetic Resonance Imaging (MRI). It can be specifically targeted to different cancer cell types and can deliver either a variety of therapeutic payloads or imaging agents to the tumor. Non-toxic and biodegradable, Polycefin™ does not provoke an immune response upon administration. Promising in vivo studies show evidence that, when attached to Polycefin™, drugs for cancer therapy could have increased treatment efficacy, lower toxicity and reduced side effects.